NASDAQ:ALGS | Key Financial Ratios | Aligos Therapeutics, Inc.

Complete source-backed ratio history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2026-06-302.19-114.53%-238.24%
2026-03-312.56-139.91%-284.13%
2025-12-313.9-27.33%-45.18%
2025-09-304.7-78.77%-120.37%
2025-06-306.31-55.07%-72.83%
2025-03-317.56-35.34%-45.74%
2024-12-312.86-187.19%452.87%
2024-09-303.81-87.03%-153.61%
2024-06-304.23-69.60%-112.65%
2024-03-316.25-77.86%-166.54%
2023-12-315.9-57.86%-95.22%
2023-09-303.32-95.13%-148.98%
2023-06-303.46-77.50%-118.12%
2023-03-313.9-68.50%-98.39%
2022-12-314.03-65.47%-92.44%
2022-09-304.91-68.19%-91.69%
2022-06-305.3-69.24%-92.26%
2022-03-314.72-64.75%-89.13%
2021-12-315.25-54.52%-69.47%
2021-09-307.15-47.53%-57.62%
2021-06-306.53-59.10%-74.14%
2021-03-318.71-49.54%-59.52%
2020-12-318.26-40.91%-49.33%
2020-09-303.69-100.13%67.54%
2020-06-3069.87%
2019-12-318.7

Annual Key Financial Ratios

DateCurrent ratioDebt/equityROAROE
2025-12-313.9-27.33%-45.18%
2024-12-312.86-187.19%452.87%
2023-12-315.9-57.86%-95.22%
2022-12-314.03-65.47%-92.44%
2021-12-315.25-54.52%-69.47%
2020-12-318.26-40.91%-49.33%
2019-12-318.7-35.67%80.54%